AI
Friday, August 21, 2020 9:52:43 AM
ABIO super lowfloat stock covid19
From Last Q´s
Basic and diluted
1,793,900
Marketcap only 33.7M
your me it is a buy in and hold. with this thiny float
only need some groups that buying in and hold. And we have a very tight float.
some news and this stock will run
we build a bigger falling wedge
presentation from august:
company augs. pres
Atrial Fibrillation –A Significant Market Opportunity•AF is the most commonsustained cardiac arrhythmia–Affects ~5.2 million (2015) Americans1–2015 worldwide prevalence of AF was estimated at 33 million2•AF is considered an epidemiccardiovascular disease –Based on the rate of increase in incidence in the U.S. and industrialized countries3•Estimated global atrial fibrillation market4–$7.2B in 2015 growing to $12.5B in 2020•ARCA estimate of Gencaro opportunity –$400M to $900M peak revenue in US; similar in EU5
From Last Q´s
Basic and diluted
1,793,900
Marketcap only 33.7M
your me it is a buy in and hold. with this thiny float
only need some groups that buying in and hold. And we have a very tight float.
some news and this stock will run
we build a bigger falling wedge
presentation from august:
company augs. pres
Atrial Fibrillation –A Significant Market Opportunity•AF is the most commonsustained cardiac arrhythmia–Affects ~5.2 million (2015) Americans1–2015 worldwide prevalence of AF was estimated at 33 million2•AF is considered an epidemiccardiovascular disease –Based on the rate of increase in incidence in the U.S. and industrialized countries3•Estimated global atrial fibrillation market4–$7.2B in 2015 growing to $12.5B in 2020•ARCA estimate of Gencaro opportunity –$400M to $900M peak revenue in US; similar in EU5
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
